Search the Newsreel

Fulcrum Therapeutics stock plunges 51% after FD...

Fulcrum Therapeutics' stock plummeted 51% after the FDA halted development of its sickle cell disease drug, pociredir, due to serious safety concerns. The FDA's decision, prompted by malignancy risks linked to similar drugs, effectively ends clinical development for pociredir, significantly impacting Fulcrum's future. This …

Fulcrum Metals reports change in significant shareholding as it advances cyanide-free tailings projects

REG - Fulcrum Metals PLC - Holding(s) in Company

Full House Resorts posts revenue growth of 5.6% in Q2 as American Place and Chamonix gain

Full House Resorts announced a 5.6% revenue growth in Q2 2026, reaching $78.1 million, driven by strong performances from its American Place and Chamonix properties. The company narrowed its quarterly loss to $8.7 million, with cash flow increasing by 19.5%. CEO Dan Lee highlighted …

Form 8K Fulcrum Therapeutics Inc For: 10 August By Investing.com

This article announces that Fulcrum Therapeutics Inc. filed a Form 8K on August 10th. The filing is a standard corporate disclosure that typically reports significant events relevant to shareholders. The brief piece is published by Investing.com, a financial markets news outlet.

Fulcrum Therapeutics appoints Alan Musso as principal accounting officer

Fulcrum Therapeutics announced that Alan Musso, its current chief financial officer, has been appointed to the additional role of principal accounting officer, effective August 7, 2026. This appointment follows the departure of Greg Tourangeau from the Vice President, Finance and principal accounting officer position. …

Discipline and Rules-Based Execution in FLGT Response

This article analyzes Fulgent Genetics Inc. (NASDAQ: FLGT), highlighting a near-term strong sentiment despite persistent mid and long-term weakness. It identifies a mid-channel oscillation pattern and an exceptional 98.2:1 risk-reward setup, targeting a 28.2% gain versus 0.3% risk. The article details three AI-generated trading …

Fulcrum Metals Secures Additional Terra North Equity in Amended Saskatchewan Uranium Deal

Fulgent Genetics, Inc. $FLGT Shares Sold by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP significantly reduced its stake in Fulgent Genetics (NASDAQ:FLGT) by 24.4% in the first quarter, selling over 217,000 shares. This comes as Fulgent Genetics reported a quarterly loss and revenue below analyst expectations, contributing to a "Hold" consensus rating among analysts. …

Fulcrum Therapeutics Inc (FULC) Earnings Forecast: Future EPS & Revenue Growth Estimates

Fulcrum Metals increases Terra North equity exposure under revised uranium agreement

Fulcrum Metals (FMET) Updates Saskatchewan Uranium Option Deal, Receives C$560,000 via Terra North Shares

REG - Fulcrum Metals PLC - Amendment to Saskatchewan uranium option agreement

EDTK Stock Price and Chart — NASDAQ:EDTK

This article provides a comprehensive overview of Skillful Craftsman Education Technology Limited (NASDAQ: EDTK) stock, including its current price, historical performance, key financial metrics, and company details. It highlights the company's online vocational training and virtual simulation experimental training services in China. The article …

Full House Resorts, Inc. (NASDAQ:FLL) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Full House Resorts, Inc. (NASDAQ:FLL) saw its shares rise 10.0% after reporting Q2 results where revenues met expectations at US$78m, but statutory losses increased to US$0.24 per share. Analysts have updated their forecasts, maintaining revenue estimates at US$312.7m for 2026 but increasing loss per …

Full House Resorts (NASDAQ:FLL) Releases Quarterly Earnings Results, Misses Estimates By $0.07 EPS

BofA Securities Maintains Fulcrum Therapeutics(FULC.US) With Sell Rating, Maintains Target Price $3

BofA Securities has maintained its Sell rating on Fulcrum Therapeutics (FULC.US) and kept its target price at $3. This indicates a continued bearish outlook from the firm regarding the company's stock performance.

Full House Resorts (NASDAQ:FLL) Downgraded to "Sell" Rating by Wall Street Zen

Wall Street Zen has downgraded Full House Resorts (NASDAQ:FLL) from "Hold" to "Sell" after the company reported a quarterly loss of $0.24 per share, missing analyst expectations. Despite the downgrade, the broader consensus from analysts remains a "Moderate Buy" with a $3.50 price target. …

Wall Street Zen Downgrades Fulgent Genetics (NASDAQ:FLGT) to Strong Sell

Wall Street Zen has downgraded Fulgent Genetics (NASDAQ:FLGT) from a "sell" to a "strong sell" rating, despite a broader analyst consensus of "hold" with a $27.50 price target. This downgrade follows Fulgent's recent quarterly earnings report, which missed analyst expectations for both EPS and …

Fulton Financial Corp (FULT) Earnings Forecast: Future EPS & Revenue Growth Estimates

Fulton Financial Corp (FULT) has an earnings forecast score of 7.14, ranking 183 out of 395 in the Banking Services industry, with an average price target of $21.00. Based on ratings from 7 analysts, most support a "Buy" trend for the stock. The company's …

Price to sales forward of Fulgent Genetics, Inc. – MUN:7F0

This page from TradingView provides financial information for Fulgent Genetics, Inc. (MUN:7F0), specifically focusing on its forward price-to-sales ratio. The content appears to be a stub or a placeholder, as no specific values or detailed data regarding the price-to-sales metric are visible.

ETFs Investing in H.B. Fuller Company Stocks

This article lists various Exchange Traded Funds (ETFs) that hold H.B. Fuller Company (FUL) stocks. It provides a detailed table including the ETF symbol, market value of FUL holdings, weight of FUL in the ETF, issuer, management style, focus, expense ratio, AUM, price, change …

Full Truck Alliance Co Ltd (YMM) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Full Truck Alliance Co Ltd (YMM), highlighting its current earnings forecast score, average price target, and analyst ratings. It includes expected revenue and EPS for upcoming quarters, along with a breakdown of analyst recommendations. The forecast indicates …

Is Full Truck Alliance (YMM) Still Trading At A Discount?

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Full Truck Alliance stock has delivered a 51.4% gain over the past three years, yet the latest valuation checks still suggest the shares screen as undervalued. Recent …

Fulgent Genetics, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:FLGT) 2026-08-07

This article presents the slide deck published by Fulgent Genetics, Inc. in conjunction with their Q2 2026 earnings call. The content is provided by Seeking Alpha's transcripts team, which publishes numerous quarterly earnings calls. The aim is to share transcript-related developments with readers.

Full Truck Alliance Co Ltd (YMM) Stock News Today

This article provides current stock information for Full Truck Alliance Co Ltd (YMM), showing its latest trading price, market capitalization, and P/E ratio. It indicates that more news will be available soon and encourages users to stay tuned for updates on earnings, analyst ratings, …

Questions remain about H.B. Fuller's closure of its Paducah site

H.B. Fuller, an adhesive manufacturing company, announced it will close its Paducah, Kentucky site by early 2027, leading to the loss of approximately 100 jobs. The company cites a strategic review of its North American manufacturing network, emphasizing that the decision does not reflect …

Fulton Financial Corporation (Nasdaq: FULT) posts Q2 2026 profit and expands loans

Noticias de acciones de Fulgent Genetics Inc (FLGT)

Kaplan Fox Encourages Investors of Fulcrum Therapeutics, Inc. (FULC) Who Suffered Losses to Contact the Firm Regarding a Securities Investigation

Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Fulcrum Therapeutics, Inc. (NASDAQ: FULC) after the company discontinued its pociredir program for sickle cell disease. The discontinuation followed heightened FDA concerns about the drug's benefit-risk profile due to malignancy risks associated with …

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Receives Consensus Recommendation of "Reduce" from Analysts

Fulcrum Therapeutics (NASDAQ:FULC) has received a consensus "Reduce" recommendation from analysts, with an average 12-month price target of $8.20. Several firms recently downgraded the stock and set lower price targets. This comes as the company missed quarterly earnings expectations and its shares remain significantly …

Fulgent Genetics, Inc. (FLGT) Stock Price, News, Quote & History

This article provides a comprehensive overview of Fulgent Genetics, Inc. (FLGT), including its stock price, historical data, company profile, and financial performance. As of August 7, the stock closed at $19.14, up 3.18%. The company specializes in clinical diagnostic and therapeutic development solutions, offering …

H.B. Fuller facility in Paducah announces 2027 closure

H.B. Fuller has announced the permanent closure of its Paducah manufacturing facility by the end of Q1 2027. The decision was made after a review of their North American manufacturing network and does not reflect the performance of the facility or its employees. The …

Skillful Craftsman Unit Signs One-Year AI Training Deal With Souche Holdings

Skillful Craftsman (NASDAQ: EDTK) to provide AI training to Souche through 2027

Skillful Craftsman Education Technology Limited, through its subsidiary Skilland Digital Intelligence Limited, has entered into an agreement with Souche Holdings Ltd. to provide AI-based training and support services. The agreement, effective from August 5, 2026, to August 4, 2027, stipulates a monthly fee of …

Full House Resorts, Inc. (NASDAQ:FLL) Given Average Rating of "Hold" by Brokerages